Jerome Ritz

64PUBLICATIONS
308CO-AUTHORS
Regenerative medicine (incl. stem cells)Respiratory diseasesGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (64)

|Sep 12, 2026
Teclistamab versus lenalidomide-dexamethasone in high-risk smoldering multiple myeloma: a randomized phase 2 trial.

|Jun 03, 2026
Long-term stability of posttranscriptional genetic silencing of BCL11A using a shmiR vector in sickle cell disease.

|May 27, 2026
Efficacy and safety of durcabtagene autoleucel in a phase 1 trial for patients with relapsed/refractory multiple myeloma.

|Apr 30, 2026
Randomized, Placebo-Controlled Trial of B-Cell Depletion for Prevention of Corticosteroid-Requiring Chronic Graft-Versus-Host Disease.

|Apr 20, 2026
Ciltacabtagene autoleucel in high-risk smoldering multiple myeloma: the CAR-PRISM phase 2 trial.

|Feb 04, 2026
Phase 1/2 trials of donor regulatory T cells for the treatment of steroid-refractory chronic graft-versus-host disease.

Maria Vd Soares, Virginia Escamilla Gómez, Rita I Azevedo

Pageof 11

Frequent Collaborators

10 joint publications

Katie Maurer

7 joint publications

Livius Penter

7 joint publications

Catherine J Wu

7 joint publications

Kenneth J Livak